Daniel Camardo

Daniel Camardo

Director/Board Member at CUE BIOPHARMA, INC.

Net worth: 563 966 $ as of 29/09/2026

57 year
Health Technology
Consumer Services
Health Services

Profile

Mr. Daniel A. Camardo is on the Board of Directors at Cue Biopharma, Inc. and CommunityHealth NFP.
Mr. Camardo was previously employed as a President-North America by Immedica Pharma AB, a Chief Executive Officer, Secretary, Director & CAO by Athersys, Inc., a President-US & Executive Vice President by Horizon Therapeutics Ltd. (Ireland), a Vice President-Sales & Operations by Clarus Therapeutics, Inc., and a Senior Director-US Commercial Operations by Astellas Pharma US, Inc. He received his undergraduate degree from Rochester Christian University and an MBA from Kellogg School of Management.

Known holdings in public companies

CompanyDateNumber of sharesValuationValuation date
08/07/2026 21,800 ( 0.3% ) 563 966 $ 29/09/2026

Daniel Camardo active positions

CompaniesPositionStart
CUE BIOPHARMA, INC. Director/Board Member 29/05/2026
Director/Board Member -

Former positions of Daniel Camardo

CompaniesPositionEnd
ATHERSYS, INC. Chief Executive Officer 30/12/2023
HORIZON THERAPEUTICS PUBLIC LIMITED COMPANY Corporate Officer/Principal 31/01/2022
Sales & Marketing 31/08/2015
Corporate Officer/Principal 31/12/2003
Corporate Officer/Principal -
See the detail of Daniel Camardo's experience

Education of Daniel Camardo

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

Connections

64

1st degree connections

9

1st degree companies

Male

Female

Members of the board

Executives

Linked companies

Private companies9

Consumer Services

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Services

Consumer Services

Health Technology

  1. Stock Market
  2. Insiders
  3. Daniel Camardo